Fred Alger Management’s Intersect ENT, Inc XENT Stock Holding History

Fred Alger Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,000	Closed	-$118K	–	603
2018 Q1	$118K	Buy	+3,000	New	+$110K	﹤0.01%	402
2016 Q1	–	Sell	-33,350	Closed	-$750K	–	618
2015 Q4	$750K	Sell	33,350 -365,855	-92%	-$7.23M	﹤0.01%	407
2015 Q3	$9.34M	Buy	399,205 +291,165	+269%	+$8.03M	0.05%	193
2015 Q2	$3.09M	Buy	+108,040	New	+$2.83M	0.01%	354

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fred Alger Management's XENT Position: Q2 2018 in Review

Fred Alger Management sold out of Intersect ENT, Inc (XENT) in Q2 2018, closing a stake of 3,000 shares — an estimated $118K sold.

Fred Alger Management first reported a position in XENT in Q2 2015 and held it in 4 quarters. The position peaked at $9.34M in Q3 2015. 160 funds tracked by Wall St. Rank hold XENT as of Q2 2018.

Fred Alger Management reported no remaining Intersect ENT, Inc position as of Q2 2018 after selling out during the quarter.
Fred Alger Management sold 3,000 Intersect ENT, Inc shares in Q2 2018, an estimated $118K.
Fred Alger Management first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 4 quarters.
Fred Alger Management's Intersect ENT, Inc position peaked at $9.34M in Q3 2015.
160 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2018.

Based on Fred Alger Management's 13F filing for Q2 2018, filed 19 Jul 2018.